Annual D&A
$84.86 M
-$684.00 K-0.80%
31 December 2023
Summary:
Supernus Pharmaceuticals annual depreciation & amortization is currently $84.86 million, with the most recent change of -$684.00 thousand (-0.80%) on 31 December 2023. During the last 3 years, it has risen by +$66.72 million (+367.77%). SUPN annual D&A is now -0.80% below its all-time high of $85.54 million, reached on 31 December 2022.SUPN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$20.10 M
-$616.00 K-2.97%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly depreciation & amortization is currently $20.10 million, with the most recent change of -$616.00 thousand (-2.97%) on 30 September 2024. Over the past year, it has dropped by -$1.75 million (-8.03%). SUPN quarterly D&A is now -8.03% below its all-time high of $21.86 million, reached on 30 September 2023.SUPN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$83.25 M
-$1.75 M-2.06%
30 September 2024
Summary:
Supernus Pharmaceuticals TTM depreciation & amortization is currently $83.25 million, with the most recent change of -$1.75 million (-2.06%) on 30 September 2024. Over the past year, it has dropped by -$787.00 thousand (-0.94%). SUPN TTM D&A is now -2.69% below its all-time high of $85.54 million, reached on 31 December 2022.SUPN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | -8.0% | -0.9% |
| 3 y3 years | +367.8% | +201.2% | +227.6% |
| 5 y5 years | +1101.5% | +1100.8% | +1138.6% |
SUPN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.8% | +367.8% | -8.0% | +201.2% | -2.7% | +227.6% |
| 5 y | 5 years | -0.8% | +1174.3% | -8.0% | +1133.3% | -2.7% | +1150.1% |
| alltime | all time | -0.8% | >+9999.0% | -8.0% | >+9999.0% | -2.7% | >+9999.0% |
Supernus Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $20.10 M(-3.0%) | $83.25 M(-2.1%) |
| June 2024 | - | $20.72 M(-0.1%) | $85.00 M(-0.0%) |
| Mar 2024 | - | $20.75 M(-4.3%) | $85.01 M(+0.2%) |
| Dec 2023 | $84.86 M(-0.8%) | $21.68 M(-0.8%) | $84.86 M(+1.0%) |
| Sept 2023 | - | $21.86 M(+5.5%) | $84.03 M(+0.1%) |
| June 2023 | - | $20.73 M(+0.6%) | $83.95 M(-1.0%) |
| Mar 2023 | - | $20.60 M(-1.2%) | $84.78 M(-0.9%) |
| Dec 2022 | $85.54 M(+162.4%) | $20.85 M(-4.3%) | $85.54 M(+10.5%) |
| Sept 2022 | - | $21.77 M(+1.0%) | $77.40 M(+24.2%) |
| June 2022 | - | $21.56 M(+0.9%) | $62.30 M(+31.5%) |
| Mar 2022 | - | $21.36 M(+68.1%) | $47.37 M(+45.3%) |
| Dec 2021 | $32.59 M(+79.7%) | $12.71 M(+90.4%) | $32.59 M(+28.3%) |
| Sept 2021 | - | $6.67 M(+0.8%) | $25.41 M(-4.4%) |
| June 2021 | - | $6.62 M(+0.4%) | $26.58 M(+15.5%) |
| Mar 2021 | - | $6.59 M(+19.4%) | $23.00 M(+26.8%) |
| Dec 2020 | $18.14 M(+172.4%) | $5.52 M(-29.6%) | $18.14 M(+27.3%) |
| Sept 2020 | - | $7.84 M(+157.5%) | $14.25 M(+76.3%) |
| June 2020 | - | $3.05 M(+75.9%) | $8.08 M(+20.4%) |
| Mar 2020 | - | $1.73 M(+6.3%) | $6.71 M(+0.8%) |
| Dec 2019 | $6.66 M(-5.7%) | $1.63 M(-2.6%) | $6.66 M(-0.9%) |
| Sept 2019 | - | $1.67 M(-0.1%) | $6.72 M(-3.0%) |
| June 2019 | - | $1.68 M(-0.2%) | $6.93 M(-1.5%) |
| Mar 2019 | - | $1.68 M(-0.8%) | $7.04 M(-0.4%) |
| Dec 2018 | $7.06 M(-13.1%) | $1.69 M(-10.2%) | $7.06 M(+0.3%) |
| Sept 2018 | - | $1.88 M(+5.8%) | $7.04 M(-26.2%) |
| June 2018 | - | $1.78 M(+4.3%) | $9.54 M(+4.8%) |
| Mar 2018 | - | $1.71 M(+2.2%) | $9.10 M(+11.9%) |
| Dec 2017 | $8.13 M | $1.67 M(-61.9%) | $8.13 M(+14.0%) |
| Sept 2017 | - | $4.38 M(+226.0%) | $7.13 M(+111.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $1.34 M(+81.2%) | $3.37 M(+24.2%) |
| Mar 2017 | - | $741.00 K(+10.4%) | $2.71 M(+13.0%) |
| Dec 2016 | $2.40 M(+160.5%) | $671.00 K(+9.8%) | $2.40 M(+20.1%) |
| Sept 2016 | - | $611.00 K(-11.2%) | $2.00 M(+24.3%) |
| June 2016 | - | $688.00 K(+60.4%) | $1.61 M(+41.5%) |
| Mar 2016 | - | $429.00 K(+58.9%) | $1.14 M(+23.3%) |
| Dec 2015 | $921.00 K(-0.8%) | $270.00 K(+22.7%) | $921.00 K(+4.9%) |
| Sept 2015 | - | $220.00 K(+1.4%) | $878.00 K(-2.3%) |
| June 2015 | - | $217.00 K(+1.4%) | $899.00 K(-1.7%) |
| Mar 2015 | - | $214.00 K(-5.7%) | $915.00 K(-1.4%) |
| Dec 2014 | $928.00 K(+25.1%) | $227.00 K(-5.8%) | $928.00 K(+1.2%) |
| Sept 2014 | - | $241.00 K(+3.4%) | $917.00 K(+4.7%) |
| June 2014 | - | $233.00 K(+2.6%) | $876.00 K(+8.6%) |
| Mar 2014 | - | $227.00 K(+5.1%) | $807.00 K(+8.8%) |
| Dec 2013 | $742.00 K(-14.8%) | $216.00 K(+8.0%) | $742.00 K(-0.7%) |
| Sept 2013 | - | $200.00 K(+22.0%) | $747.00 K(-1.6%) |
| June 2013 | - | $164.00 K(+1.2%) | $759.00 K(-6.1%) |
| Mar 2013 | - | $162.00 K(-26.7%) | $808.00 K(-7.2%) |
| Dec 2012 | $871.00 K(-0.9%) | $221.00 K(+4.2%) | $871.00 K(-0.8%) |
| Sept 2012 | - | $212.00 K(-0.5%) | $878.00 K(-1.3%) |
| June 2012 | - | $213.00 K(-5.3%) | $890.00 K(-0.7%) |
| Mar 2012 | - | $225.00 K(-1.3%) | $896.00 K(+1.9%) |
| Dec 2011 | $879.00 K(-26.0%) | $228.00 K(+1.8%) | $879.00 K(+35.0%) |
| Sept 2011 | - | $224.00 K(+2.3%) | $651.00 K(+52.5%) |
| June 2011 | - | $219.00 K(+5.3%) | $427.00 K(+105.3%) |
| Mar 2011 | - | $208.00 K | $208.00 K |
| Dec 2010 | $1.19 M(+10.8%) | - | - |
| Dec 2009 | $1.07 M(-3.9%) | - | - |
| Dec 2008 | $1.11 M(+19.6%) | - | - |
| Dec 2007 | $932.20 K | - | - |
FAQ
- What is Supernus Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual D&A year-on-year change?
- What is Supernus Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly D&A year-on-year change?
- What is Supernus Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM D&A year-on-year change?
What is Supernus Pharmaceuticals annual depreciation & amortization?
The current annual D&A of SUPN is $84.86 M
What is the all time high annual D&A for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual depreciation & amortization is $85.54 M
What is Supernus Pharmaceuticals annual D&A year-on-year change?
Over the past year, SUPN annual depreciation & amortization has changed by -$684.00 K (-0.80%)
What is Supernus Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of SUPN is $20.10 M
What is the all time high quarterly D&A for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly depreciation & amortization is $21.86 M
What is Supernus Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, SUPN quarterly depreciation & amortization has changed by -$1.75 M (-8.03%)
What is Supernus Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of SUPN is $83.25 M
What is the all time high TTM D&A for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM depreciation & amortization is $85.54 M
What is Supernus Pharmaceuticals TTM D&A year-on-year change?
Over the past year, SUPN TTM depreciation & amortization has changed by -$787.00 K (-0.94%)